Searchable abstracts of presentations at key conferences in endocrinology

ea0021p385 | Thyroid | SFEBES2009

Atypical presentation of Riedel’s thyroiditis: multifocal nodular fibrosis and resolution with levothyroxine

Kumar Sampath Satish , Sheila Fraser , Scarsbrook Andrew , Maclennan Ken , Lansdown Mark , Murray Robert

In patients presenting with a diffusely enlarged hard thyroid gland the differential diagnosis lies between thyroid carcinoma, lymphoma, and Riedel’s thyroiditis. We present a case of Riedel’s thyroiditis with multifocal nodular sclerosis, which improved with levothyroxine replacement.A 40-year-old woman presented with a 3 months history of neck swelling, dysphagia and breathlessness on exertion. Examination revealed a hard, fixed, diffuse goit...

ea0019p243 | Pituitary | SFEBES2009

Growth hormone deficiency in adults: the NICE criteria do not discriminate an adverse cardiovascular phenotype

Aragon Alonso Aurora , Sherlock Mark , McGregor Elizabeth , Murray Robert , Stewart Paul M , Toogood Andrew A

Severe growth hormone (GH) deficiency in adults is associated with adverse changes in quality of life (QoL), body composition and cardiovascular risk profile. NICE guidance restricts GH replacement in the UK to those with impaired QoL, defined by a score of >11 in the QoL-AGHDA questionnaire.Aims: To assess whether the NICE guidance differentiates other clinical or biochemical features in GH deficient adults.Patients and...

ea0015p273 | Pituitary | SFEBES2008

Critical evaluation of the diagnostic utility of the simplified intramuscular glucagon stimulation test (IMGST)

Bedford Matthew , Sugunendran Suma , Haniff Haliza , Fent Laura , Blyth Christian , Aye Mo , Murray Robert

The use of the simplified IM glucagon stimulation test (IMGST) over its standard counterpart in the diagnosis of GH and cortisol deficiency has been advocated. Despite apparent comparable diagnostic utility, the simplified IMGST is capable of producing false positive results, raising the potential for misdiagnosis if relied upon exclusively.The aim of this study was to re-evaluate the diagnostic utility of the two forms of the IMGST, ascertaining the mag...

ea0013p235 | Neuroendocrinology and behaviour (including pituitary) | SFEBES2007

Growth hormone sensitivity in GH deficient (GHD) hypopituitary adults is dependent on gender, but independent of timing of onset

Columb Breeda , Jostel Andreas , Mukherjee Annice , Smethurst Linda , Shalet Stephen , Murray Robert

Females release 2–3 fold greater GH compared with males whilst maintaining similar IGF-I levels. IGF-I generation tests in healthy subjects suggest this discordancy results from resistance to GH in females. In GHD females the presumed relative insensitivity to GH is reflected by a lower basal IGF-I and higher GH maintenance doses during replacement. GHD adults of childhood- (CO) and adult-onset (AO) show CO-GHD adults to have lower basal IGF-I values and require higher ma...

ea0056p749 | Neuroendocrinology | ECE2018

Latest safety outcomes from the PATRO adults study of omnitrope® for the treatment of adult patients with growth hormone deficiency

Beck-Peccoz Paolo , Hoybye Charlotte , Murray Robert , Simsek Suat , Zabransky Markus , Zouater Hichem , Stalla Gunter

Introduction: Omnitrope® (Sandoz) is a recombinant human growth hormone (rhGH) and was the first biosimilar medicine approved by the European Medicines Agency. PATRO Adults is an international, longitudinal, non-interventional study of the long-term safety and efficacy of Omnitrope® in adults treated in routine clinical practice. The study provides data on the long-term safety of rhGH in adult patients with severe GH deficiency (GHD). Here we pr...

ea0094p3 | Adrenal and Cardiovascular | SFEBES2023

Assessing the Impact of Residual Adrenal Function on the prevalence of adrenal crises and intercurrent infections

Lynch Julie , McLaren David , Cassidy Samantha , Kyriakakis Nikolaos , Seejore Khyatisha , Murray Robert

Objective: Determinants of why only a subset of patients with adrenal insufficiency (AI) experience recurrent adrenal crises (AC) and intercurrent illnesses are not well understood. This study aimed to identify whether residual adrenal function (RAF), defined by the peak response to a provocative test undertaken before commencing glucocorticoids, may help explain differences in prevalence.Design and Methods: Patients wit...

ea0081rc4.3 | Rapid Communications 4: Pituitary and Neuroendocrinology 1 | ECE2022

Pre-treatment GH levels and number of therapeutic interventions for acromegaly management are predictive of altered MRI bone shape and severity of arthropathy in acromegaly

Kyriakakis Nikolaos , Bowes Michael , Lynch Julie , Kingsbury Sarah R , M Orme Steve , Murray Robert D , Conaghan Philip G

Introduction: Emerging research in 3D-bone shape has provided new insights into the pathogenesis of osteoarthritis (OA). OA patients have increased subchondral bone area, associated with higher prevalence of cartilage loss. Higher B-score, a novel, machine learning-derived OA bone biomarker, is associated with increased OA symptom severity and structural progression. Arthropathy, despite being the commonest cause of morbidity amongst acromegaly patients, remains one of the und...

ea0065p271 | Neuroendocrinology | SFEBES2019

Increased clot density in patients with acromegaly: the role of the adverse metabolic profile and disease activity to the increased thrombotic potential

Kyriakakis Nikolaos , Pechlivani Nikoletta , Lynch Julie , Oxley Natalie , Phoenix Fladia , Seejore Khyatisha , Orme Steve , Ajjan Ramzi , Murray Robert

Introduction: Patients with acromegaly have increased mortality, primarily related to cardiovascular/cerebrovascular disease. The objective of this study was to evaluate whether GH/IGF-1 excess increases vascular disease by adversely affecting fibrin network characteristics.Methods: In this case–control study, 40 patients with acromegaly (21 males, age 53±13 years, 45% disease remission) and 40 age and gender-matched controls were recruited. Cl...

ea0038p151 | Neoplasia, cancer and late effects | SFEBES2015

Pituitary-related outcomes of cranial radiotherapy (cXRT) in adults with gliomas

Kyriakakis Nikolaos , Lynch Julie , Orme Steve M , Gerrard Georgina , Hatfield Paul , Loughrey Carmel , Short Susan C , Murray Robert D

Introduction: Radiation-induced hypopituitarism has been well-described in childhood-onset brain tumour survivors, however in adults has received less attention. The aim of this study was to assess the pituitary-related outcomes following cXRT in adults with extra-sellar gliomas.Methods: We retrospectively collected longitudinal data regarding pituitary-related outcomes from medical records of 59 patients, diagnosed with extra-sellar gliomas in adulthood...

ea0038p156 | Neoplasia, cancer and late effects | SFEBES2015

Adverse metabolic profile in long-term survivors of adult and childhood-onset brain tumours: the role of growth hormone deficiency

Lynch Julie , Kyriakakis Nikolaos , Kumar Satish S , Ajjan Ramzi , Gerrard Georgina , Loughrey Carmel , Glaser Adam , Murray Robert D

Introduction: Childhood-onset brain tumour (CO-BT) survivors demonstrate elevated standardized mortality rates for cardiac disease. Adverse lipid profile and body composition contribute to the increased cardiovascular risk. Little is known about the metabolic changes in long-term survivors of adult-onset brain tumours (AO-BT).Methods: We performed a cross-sectional study to compare cardiovascular risk parameters in CO-BT with AO-BT survivors and healthy ...